<i>MGMT</i> Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study

<i>MGMT</i> Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study

Glioblastoma is the most malignant central nervous system tumor, which represents 50% of all glial tumors. The understanding of glioma genesis, prognostic evaluation, and treatment planning has been significantly enhanced by the discovery of molecular genetic biomarkers. This study aimed to evaluate...

Full description

Bibliographic Details
Main Authors: Mateusz Szylberg, Paweł Sokal, Paulina Śledzińska, Marek Bebyn, Stanisław Krajewski, Łukasz Szylberg, Aneta Szylberg, Tadeusz Szylberg, Kamil Krystkiewicz, Marcin Birski, Marek Harat, Robert Włodarski, Jacek Furtak
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biomedicines
Subjects:
glioblastoma
<i>MGMT</i>
prognostic factor
survival prediction
surgical resection
Online Access:https://www.mdpi.com/2227-9059/10/8/2030

Internet

https://www.mdpi.com/2227-9059/10/8/2030

Similar Items